# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095383
Filing Date
2024-08-12
Accepted
2024-08-12 16:00:19
Documents
68
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | glto-20240630.htm iXBRL | 10-Q | 1451966
2 | EX-10.1 | glto-ex10_1.htm | EX-10.1 | 65574
3 | EX-10.2 | glto-ex10_2.htm | EX-10.2 | 29327
4 | EX-31.1 | glto-ex31_1.htm | EX-31.1 | 18935
5 | EX-31.2 | glto-ex31_2.htm | EX-31.2 | 18948
6 | EX-32.1 | glto-ex32_1.htm | EX-32.1 | 15307
| Complete submission text file | 0000950170-24-095383.txt |  | 6010465

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | glto-20240630.xsd | EX-101.SCH | 891284
71 | EXTRACTED XBRL INSTANCE DOCUMENT | glto-20240630_htm.xml | XML | 917760

Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39655 | Film No.: 241196611
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)